Endothelin-mediated changes in gene expression in isolated purified rat retinal ganglion cells

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 10, 2015, Pages 6144-6161

  He, Shaoqing ^a   Park, Yong H ^a   Yorio, Thomas ^a   Krishnamoorthy, Raghu R ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Endothelins; Gene expression; Glaucoma; Retinal ganglion cells

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYTOKINE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; MATRIX METALLOPROTEINASE; NEUROMODULIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C JUN; PROTEIN S 100; TRANSCRIPTION FACTOR POU4F2; EYE PROTEIN; MESSENGER RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; RETINA DEGENERATION; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELINS; EYE PROTEINS; FEMALE; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL DEGENERATION; RETINAL GANGLION CELLS; RNA, MESSENGER;

EID: 84942112662     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-16569     Document Type: Article

References (102)

1. Sokolovsky M. Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol Ther. 1995;68:435-471.
2. Whensen J, Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary openangle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol. 1997;235:551-552.
3. Tezel G, Kass M, Kolker A, Becker B, Wax M. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma. 1997;6:83-89.
4. Kallberg ME, Brooks DE, Garcia-Sanchez GA, Komaromy AM, Szabo NJ, Tian L. Endothelin 1 Levels in the aqueous humor of dogs with glaucoma. J Glaucoma. 2002;11:105-109.
5. Prasanna G, Hulet C, Desai D, et al. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol Res. 2005;51:41-50.
6. Oku H, Sugiyama T, Kojima S, Watanabe T, Azuma I. Experimental optic cup enlargement caused by endothelin-1-induced chronic optic nerve head ischemia. Surv Ophthalmol. 1999;44:S74-S84.
7. Felx M, Guyot M-C, Isler M, et al. Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kB in human osteosarcoma. Clinic Sci. 2006;110:645-654.
8. Liu S, Premont RT, Kontos CD, Huang J, Rockey DC. Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein bc subunit signaling to protein kinase B/Akt. J Biol Chem. 2003;278:49929-49935.
9. Grant K, Loizidou M, Taylor I. Endothelin-1: a multifunctional molecule in cancer. Br J Cancer. 2003;88:163-166.
10. Nambi P, Clozel M, Feuerstein G. Endothelin and heart failure. Heart Fail Rev. 2001;6:335-340.
11. Nelson J, Bagnato A, Battistini B, Nisen P. The endothelin axis: emerging role in cancer. Nature Rev Cancer. 2003;3:110-116.
12. Sokolovsky M. Endothelin receptor heterogeneity, G-proteins, and signaling via cAMP and cGMP cascades. Cell Mol Neurobiol. 1995;15:561-571.
13. Sugden PH, Clerk A. Endothelin Signalling in the Cardiac Myocyte And Its Pathophysiological Relevance. Curr Vascu Pharmacol. 2005;3:343-351.
14. Kedzierski RM, Yanagisawa M. Endothelin system: the doubleedged sword in health and disease. Ann Rev Pharmacol Toxicol. 2001;41:851-876.
15. Rosendorff C. Endothelin, vascular hypertrophy, and hypertension. Cardiovascu Drugs Ther. 1997;10:795-802.
16. Yorio T, Krishnamoorthy R, Prasanna G. Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma. 2002;11:259-270.
17. Prasanna G, Narayan S, Krishnamoorthy RR, Yorio T. Eyeing endothelins: a cellular perspective. Mol Cell Biochem. 2003; 253:71-88.
18. Goraca A. New views on the role of endothelin. Endocri Regul. 2002;36:161-167.
19. Sugden P. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol. 2003;35:871-886.
20. Bagnato A, Natali PG. Targeting endothelin axis in cancer. Cancer Treat Res. 2004;119:293-314.
21. Narayan S, Prasanna G, Krishnamoorthy RR, Zhang X, Yorio T. Endothelin-1 Synthesis and Secretion in Human Retinal Pigment Epithelial Cells (ARPE-19): differential regulation by cholinergics and TNF-{alpha}. Invest Ophthalmol Vis Sci. 2003;44:4885-4894.
22. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci. 2004;45:1247-1258.
23. Orgul S, Cioffi G, Bacon D, Van Buskirk E. An endothelin-1-induced model of chronic optic nerve ischemia in rhesus monkeys. J Glaucoma. 1996;5:135-138.
24. Orgul S, Cioffi G, Wilson D, Bacon D, Van Buskirk E. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest Ophthalmol Vis Sci. 1996;37:1860-1869.
25. Chauhan BC, LeVatte TL, Jollimore CA, et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004;45:144-152.
26. Cioffi G, Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur J Ophthalmol. 1999;(suppl 1):S34-S36.
27. Cioffi G, Orgul S, Onda E, Bacon D, Van Buskirk E. An in vivo model of chronic optic nerve ischemia: the dose-dependent effects of endothelin-1 on the optic nerve microvasculature. Curr Eye Res. 1995;14:1147-1153.
28. Stokely ME, Brady ST, Yorio T. Effects of endothelin-1 on components of anterograde axonal transport in optic nerve. Invest Ophthalmol Vis Sci. 2002;43:3223-3230.
29. Minton AZ, Phatak NR, Stankowska DL, et al. Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma. PLoS One. 2012;7:e43199.
30. Barres BA, Silverstein BE, Corey DP, Chun LL. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron. 1988;1: 791-803.
31. Mueller BH II, Park Y, Daudt DR III, et al. Sigma-1 receptor stimulation attenuates calcium influx through activated Ltype voltage gated calcium channels in purified retinal ganglion cells. Exp Eye Res. 2013;107:21-31.
32. Huangda W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44-57.
33. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1-13.
34. Pagano M, Theodoras AM, Tam SW, Draetta GF. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev. 1994;8:1627-1639.
35. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta. 1999; 1450:191-231.
36. Donato R, Cannon BR, Sorci G, et al. Functions of S100 proteins. Curr Mol Med. 2013;13:24-57.
37. Kou I, Nakajima M, Ikegawa S. Expression and regulation of the osteoarthritis-associated protein asporin. J Biol Chem. 2007;282:32193-32199.
38. He S, Minton AZ, Ma H-Y, Stankowska DL, Sun X, Krishnamoorthy RR. Involvement of AP-1 and C/EBPb in upregulation of endothelin B (ETB) receptor expression in a rodent model of glaucoma. PLoS One. 2013;8:e79183.
39. Mu X, Beremand PD, Zhao S, et al. Discrete gene sets depend on POU domain transcription factor Brn3b/Brn-3.2/POU4f2 for their expression in the mouse embryonic retina. Development. 2004;131:1197-1210.
40. Wang SW, Mu X, Bowers WJ, et al. Brn3b/Brn3c double knockout mice reveal an unsuspected role for Brn3c in retinal ganglion cell axon outgrowth. Development. 2002; 129:467-477.
41. Nilsson M, Ford J, Bohm S, Toftgard R. Characterization of a nuclear factor that binds juxtaposed with ATF3/Jun on a composite response element specifically mediating induced transcription in response to an epidermal growth factor/Ras/Raf signaling pathway. Cell Growth Differ. 1997;8:913-920.
42. Guo Y, Johnson EC, Cepurna WO, Dyck JA, Doser T, Morrison JC. Early gene expression changes in the retinal ganglion cell layer of a rat glaucoma model. Invest Ophthalmol Vis Sci. 2011;52:1460-1473.
43. Atsumi T, Singh R, Sabharwal L, et al. Inflammation amplifier, a new paradigm in cancer biology. Cancer Res. 2014;74:8-14.
44. Kumar J, Ward AC. Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications. Biochim Biophys Acta. 2014;1845:117-125.
45. Siveen KS, Sikka S, Surana R, et al. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta. 2014;1845:136-154.
46. Levkovitch-Verbin H, Quigley HA, Martin KRG, et al. The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma. Exp Eye Res. 2005;80:663-670.
47. Krishnamoorthy RR, Rao VR, Dauphin R, Prasanna G, Johnson C, Yorio T. Role of the ETB receptor in retinal ganglion cell death in glaucoma. Can J Physiol Pharmacol. 2008;86:380-393.
48. Morga E, Faber C, Heuschling P. Stimulation of Endothelin B receptor modulates the inflammatory activation of rat astrocytes. J Neurochem. 2000;74:603-612.
49. Rogers S, Peters C, Pomonis J, Hagiwara H, Ghilardi J, Mantyh P. Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS. Glia. 2003;41:180-190.
50. Peters CM, Rogers SD, Pomonis JD, et al. Endothelin receptor expression in the normal and injured spinal cord: potential involvement in injury-induced ischemia and gliosis. Exp Neurol. 2003;180:1-13.
51. Rogers SD, Demaster E, Catton M, et al. Expression of Endothelin-B receptors by gliain vivois increased after CNS injury in rats, rabbits, and humans. Exp Neurol. 1997;145: 180-195.
52. Wang X, LeVatte TL, Archibald ML, Chauhan BC. Increase in endothelin B receptor expression in optic nerve astrocytes in endothelin-1 induced chronic experimental optic neuropathy. Exp Eye Res. 2009;88:378-385.
53. Howell GR, Macalinao DG, Sousa GL, et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011;121:1429-1444.
54. Herdegen T, Skene P, Bahr M. The c-Jun transcription factor - bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci. 1997;20:227-231.
55. Raivich G, Behrens A. Role of the AP-1 transcription factor c- Jun in developing, adult and injured brain. Prog Neurobiol. 2006;78:347-363.
56. Raivich G, Bohatschek M, Da Costa C, et al. The AP-1 Transcription Factor c-Jun is required for efficient axonal regeneration. Neuron. 2004;43:57-67.
57. Borsello T, Forloni G. JNK signalling: a possible target to prevent neurodegeneration. Curr Pharm Des. 2007;13: 1875-1886.
58. Fernandes KA, Harder JM, Fornarola LB, et al. JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death. Neurobiol Dis. 2012;46:393-401.
59. Sun H, Wang Y, Pang I-H, et al. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension. Mol Vis. 2011;17:864-875.
60. Skene JH, Willard M. Changes in axonally transported proteins during axon regeneration in toad retinal ganglion cells. J Cell Biol. 1981;89:86-95.
61. Woolf CJ, Reynolds ML, Molander C, O’Brien C, Lindsay RM, Benowitz LI. The growth-associated protein gap-43 appears in dorsal root ganglion cells and in the dorsal horn of the rat spinal cord following peripheral nerve injury. Neuroscience. 1990;34:465-478.
62. Neve RL, Finch EA, Bird ED, Benowitz LI. Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc Natl Acad Sci U S A. 1988;85: 3638-3642.
63. Benowitz LI, Routtenberg A. A membrane phosphoprotein associated with neural development, axonal regeneration, phospholipid metabolism, and synaptic plasticity. Trends Neurosci. 1987;10:527-532.
64. Benowitz LI, Perrone-Bizzozero NI, Finklestein SP. Molecular properties of the growth-associated protein GAP-43 (B-50). J Neurochem. 1987;48:1640-1647.
65. da Cunha A, Vitkovic L. Regulation of immunoreactive GAP-43 expression in rat cortical macroglia is cell type specific. J Cell Biol. 1990;111:209-215.
66. Vitkovic L, Steisslinger HW, Aloyo VJ, Mersel M. The 43-kDa neuronal growth-associated protein (GAP-43) is present in plasma membranes of rat astrocytes. Proc Natl Acad Sci U S A. 1988;85:8296-8300.
67. Neve RL, Coopersmith R, McPhie DL, et al. The neuronal growth-associated protein GAP-43 interacts with rabaptin-5 and participates in endocytosis. J Neurosci. 1998;18:7757-7767.
68. Li Y, Jiang N, Powers C, Chopp M. Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke. 1998;29: 1972-1981.
69. Doster SK, Lozano AM, Aguayo AJ, Willard MB. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron. 1991;6:635-647.
70. Li GL, Farooque M, Holtz A, Olsson Y. Increased expression of growth-associated protein 43 immunoreactivity in axons following compression trauma to rat spinal cord. Acta Neuropathol. 1996;92:19-26.
71. Michler SA, Illing RB. Acoustic trauma induces reemergence of the growth- and plasticity-associated protein GAP-43 in the rat auditory brainstem. J Comp Neurol. 2002;451:250-266.
72. Hulsebosch CE, DeWitt DS, Jenkins LW, Prough DS. Traumatic brain injury in rats results in increased expression of Gap-43 that correlates with behavioral recovery. Neurosci Lett. 1998;255:83-86.
73. Eggen BJL, Nielander HB, Rensen-de Leeuw MGA, Schotman P, Gispen WH, Schrama LH. Identification of two promoter regions in the rat B-50/GAP-43 gene. Mol Brain Res. 1994;23: 221-234.
74. Schaden H, Stuermer CA, Bahr M. GAP-43 immunoreactivity and axon regeneration in retinal ganglion cells of the rat. J Neurobiol. 1994;25:1570-1578.
75. Clerk A, Bogoyevitch M, Anderson M, Sugden P. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen- activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem. 1994;269: 32848-32857.
76. Robin P, Boulven I, Desmyter C, Harbon S, Leiber D. ET-1 stimulates ERK signaling pathway through sequential activation of PKC and Src in rat myometrial cells. Am J Physiol Cell Physiol. 2002;283:C251-C260.
77. Robin P, Boulven I, Bole-Feysot C, Tanfin Z, Leiber D. Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells. Am J Physiol Cell Physiol. 2004;286:C798-C806.
78. He S, Dibas A, Yorio T, Prasanna G. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells. Exp Biol Med. 2007;232:370-384.
79. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem. 2007;282:31317-31331.
80. Joo JH, Yoon SY, Kim JH, et al. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J Cell Biochem. 2008;103:1183-1197.
81. Khositseth S, Pisitkun T, Slentz DH, et al. Quantitative protein and mRNA profiling shows selective post-transcriptional control of protein expression by vasopressin in kidney cells. Mol Cell Proteomics. 2011;10:M110 004036.
82. Hernandez M, Pena J. The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol. 1997;115:389-395.
83. Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retinal Eye Res. 2000; 19:297-321.
84. Hernandez M, Andrzejewska W, Neufeld A. Changes in the extracellular matrix of the human optic nerve head in primary open-angle glaucoma. Am J Ophthalmol. 1990;109: 180-188.
85. Johnson EC, Morrison JC, Farrell S, Deppmeier L, Moore CG, McGinty MR. The effect of chronically elevated intraocular pressure on the rat optic nerve head extracellular Matrix. Exp Eye Res. 1996;62:663-674.
86. Morrison JC, Johnson EC, Cepurna W, Jia L. Understanding mechanisms of pressure-induced optic nerve damage. Prog Retinal Eye Res. 2005;24:217-240.
87. Westermarck J, Kahari V-M Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999; 13:781-792.
88. Gardner J, Ghorpade A. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res. 2003;74:801-806.
89. Tian X, Tang G, Chen Y. The effects of endothelin-1 and selective endothelin receptor-type A antagonist on human renal interstitial fibroblasts in vitro. Zhonghua Yi Xue Za Zhi. 2002;82:5-9.
90. Fraccarollo D, Bauersachs J, Kellner M, Galuppo P, Ertl G. Cardioprotection by long-term ETA receptor blockade and ACE inhibition in rats with congestive heart failure: monoversus combination therapy. Cardiovascul Res. 2002;54:85-94.
91. Fraccarollo D, Galuppo P, Bauersachs J, Ertl G. Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling. Cardiovascu Res. 2002;54:559-567.
92. Gomez-Garre D, Ruiz-Ortega M, Ortego M, et al. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension. 1996;27:885-892.
93. Nakamura T, Ebihara I, Tomino Y, Koide H. Effect of a specific endothelin A receptor antagonist on murine lupus nephritis. Kidney Int. 1995;47:481-489.
94. He S, Prasanna G, Yorio T. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Invest Ophthalmol Vis Sci. 2007;48:3737-3745.
95. Rao VR, Krishnamoorthy RR, Yorio T. Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa. Exp Eye Res. 2008;86:886-894.
96. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci. 2005;46:175-182.
97. Schinelli S, Zanassi P, Paolillo M, Wang H, Feliciello A, Gallo V. Stimulation of endothelin B receptors in astrocytes induces cAMP response element-binding protein phosphorylation and c-fos expression via multiple mitogen-activated protein kinase signaling pathways. J Neurosci. 2001;21:8842-8853.
98. Shichiri M, Sedivy JM, Marumo F, Hirata Y. Endothelin-1 is a potent survival factor for c-Myc-dependent apoptosis. Mol Endocrinol. 1998;12:172-180.
99. Chen S, Mukherjee S, Chakraborty C, Chakrabarti S. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am J Physiol Cell Physiol. 2003;284:C263-C272.
100. Iwai-Kanai E, Hasegawa K. Intracellular signaling pathways for norepinephrine- and endothelin-1-mediated regulation of myocardial cell apoptosis. Mol Cell Biochem. 2004;259:163-168.
101. Chintalgattu V, Katwa LC. Role of protein kinase Cd in endothelin-induced type I collagen expression in cardiac myofibroblasts isolated from the site of myocardial infarction. J Pharmacol Exp Ther. 2004;311:691-699.
102. Hua H, Goldberg HJ, Fantus IG, Whiteside CI. High glucoseenhanced mesangial cell extracellular signal-regulated protein kinase activation and a1(IV) collagen expression in response to endothelin-1: role of specific protein kinase C isozymes. Diabetes. 2001;50:2376-2383.